Patents by Inventor Christopher J. Sweeney

Christopher J. Sweeney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug Combinations to Treat Cancer
    Publication number: 20160082019
    Abstract: This invention relates to the combination of cabozantinib and abiraterone to treat cancer, particularly castration resistant prostate cancer.
    Type: Application
    Filed: April 4, 2014
    Publication date: March 24, 2016
    Inventors: Christopher J. Sweeney, Phili W. Kantoff
  • Use of parthenolide to inhibit cancer
    Patent number: 6890946
    Abstract: The invention provides a method comprising the use of parthenolide, including its analogs, to treat cancer or conditions characterized by abnormal angiogenesis.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: May 10, 2005
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Harikrishna Nakshatri, Christopher J. Sweeney
  • Use of parthenolide to inhibit cancer
    Publication number: 20030125373
    Abstract: The invention provides a method comprising the use of parthenolide, including its analogs, to treat cancer or conditions characterized by abnormal angiogenesis.
    Type: Application
    Filed: June 21, 2002
    Publication date: July 3, 2003
    Inventors: Harikrishna Nakshatri, Christopher J. Sweeney